NCT01880944

Brief Summary

Non-contrast MRI with T2 fat suppression has been a useful imaging modality in evaluation spinal trauma. However, the role of contrast enhancement has not investigated in patients with spinal trauma. Therefore, this prospective study aims to evaluate the usefulness of contrast enhanced MRI for spinal trauma W/U clinically. The study hypothesis is that there is no additional gain in addition of contrast enhanced study to routine non-contrast MRI.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2013

Typical duration for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 14, 2013

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 19, 2013

Completed
5 days until next milestone

Study Start

First participant enrolled

June 24, 2013

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 14, 2016

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 14, 2017

Completed
Last Updated

October 5, 2018

Status Verified

October 1, 2018

Enrollment Period

3.5 years

First QC Date

June 14, 2013

Last Update Submit

October 3, 2018

Conditions

Keywords

spinetraumaMRIcontrast

Outcome Measures

Primary Outcomes (2)

  • The rate (%) of change of treatment option between non-surgery vs. surgery, after review of enhanced MRI finding, compared with non-enhanced MRI only

    The rate (%) of change of treatment option between non-surgery vs. surgery, after review of enhanced MRI finding, compared with non-enhanced MRI only

    2 months

  • Confidence level

    Confidence level (1, definitely negative; 2, probably negative; 3, equivocal; 4, probably positive; 5, definitely positive) for lesion of spinal body, posterior compartment, soft tissue (posterior ligamentous complex of thoracolumbar spine and discoligamentous complex of cervical spine), spinal cord, and epidural/subdural hematoma/hemorrhage

    2 months

Secondary Outcomes (2)

  • Diagnostic accuracy of non-enhanced and enhanced MRI

    2 months

  • Inter- and intra-reader agreement of confidence level

    2 months

Other Outcomes (2)

  • Prognostic value of enhanced MRI

    2 months

  • The rate (%) of change of treatment plan

    2 months

Study Arms (2)

ER-spine trauma

patients with spinal trauma, who initially visits in emergency room

Other: NC-MRI, CE-MRI

OUT-spine trauma

patients with spinal trauma, who initially visits in outpatient clinic

Other: NC-MRI, CE-MRI

Interventions

non-contrast spine MRI(NC-MRI) contrast-enhanced spine MRI(CE-MRI)

Also known as: non-contrast spine MRI(NC-MRI), contrast-enhanced spine MRI(CE-MRI)
ER-spine traumaOUT-spine trauma

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

300 patients that fulfilled the following criteria

You may qualify if:

  • Patients who provided the informed consent
  • Patients with spinal trauma
  • Patients with age of 19 years or more

You may not qualify if:

  • Relative contraindication of MR contrast
  • previous history of any adverse event after injection of magnetic resonance contrast
  • pregnant or breast-feeding state
  • within 2 weeks after liver transplantation
  • epileptic disorder
  • Patients impossible with follow-up period of at least 2 months clinically
  • Patients with severely impaired renal function of estimated glomerular filtration rate (GFR) \< 30 mL/min/1.73m2 and/or on dialysis
  • patients with age less than 19 years

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Guen Young Lee

Seongnam-si, Gyenggi-do, 463-707, South Korea

Location

Seoul National University Bundang Hospital

Seongnam-si, Gyeonggi-do, 763-707, South Korea

Location

MeSH Terms

Conditions

Wounds and Injuries

Study Officials

  • Guen Young Lee, MD

    Seoul National University Bundang Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
2 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Cinical assistant professor

Study Record Dates

First Submitted

June 14, 2013

First Posted

June 19, 2013

Study Start

June 24, 2013

Primary Completion

December 14, 2016

Study Completion

February 14, 2017

Last Updated

October 5, 2018

Record last verified: 2018-10

Locations